In summary, the high expression of DNMT1 serum protein may play a major role in the early development of lung cancer and is a risk factor for non-small-cell lung cancer; the positive expression of HER2 is of great significance to the development of lung cancer in the middle and late stages. Here, ERBB2 is linked to lung carcinoma.